|
Editorial Review from Barnes and Noble
Editorial Reviews
Director Dan Ireland adapts writer Robert Bazell's autobiographical novel Her-2 to the screen with this made-for-Lifetime drama concerning UCLA oncologist and researcher Dr. Dennis Slamon, creator of the promising breast cancer drug Herceptin. Convinced that his revolutionary drug could effectively switch off cancer cells for women with tumors of the Her-2+ (Human Epidermal growth factor Receptor 2-positive) without radiation treatment, Dr. Slamon raised funds for his research with the help of Ron Perelman, Lilly Tartikoff, and the extended Revlon family. Later, as Dr. Slamon attempted to cut through the bureaucratic red tape and get his drug approved, a number of brave patients who had volunteered for the clinical tests of Herceptin sadly succumbed to their cancer. But all hope wasn't lost, because in 1998 the FDA finally approved the use of Herceptin to treat breast cancer, giving hope to millions of women and their families across the country.
__________________
9/15/08 (age 52) - Mammo: calcifications
9/22/08 - Biopsy: DCIS, grade 3. ER,PR status: Pos. in 75-90% of tumor cells.
10/01/08 - Ob/Gyn appt.: found complex, mostly cystic mass on right ovary - 11cmx12cmx 8cm
10/15/08 - Hysterectomy & Oophorectomy, Lumpectomy: Cyst on uterus, not ovary - all was benign. Breast - 5 of 6 bad margins. 2 Sentinel Lymph nodes removed, both negative. Stage 0, Tis, N0
12/11/08 - Mastectomy & DIEP reconstruction: Surprise! 2 cm Invasive DC, grade 2 found. One benign internal mammary lymph node. Stage 1, T1c, N0, all clean margins. ER+ (Proportion Score = 2/5, Intensity Score = 2/3) and PR+(Proportion Score = 3/5, Intensity Score = 2/3)
HER2 score = 3+
1/09/09 - Oncotype DX: Recurrence S/core of 60 !?!?! ER status is NEG!! PR staus is NEG! HER2 score = 12.2 (still positive, greater than 11.5 is positive).
1/20/09 - Started chemo: TCH
5/26/09 - FINISHED CHEMO!
1/05/10 - FINISHED HERCEPTIN!
1/22/10 - Port-a-catheter removed!
3/07/18 - Still NED
9/10/23 - Still NED
|